KOLINPHARMA
brevetti
Patents
Our products are unique.
Patent is an amazing tool for enterprises, which allows them to protect their own investments in research and innovation and to acquire additional economical resources through the economic management of its exploitation rights.

Today many companies’ value consists of 90% of intangible assets, mainly composed by industrial property rights. A company with the patent protection is in the position of preventing another company to produce, commercialize and sell a product or a competition, violating its own patent protection.

The patents portfolio is a demonstration of the high quality, specialization and technology capabilities of the company. A patent determines a company enrichment, and also its help to increase the market position.

Kolinpharma received 4 industrial patents and specifically:


Almetax patented

ALMETAX Easy
Industrial invention patent n. 0001425921
It was granted for showing, in a statistically significant way, the efficiency of the synergy between active substances of ALMETAX Easy, for a composition, useful for prevention and treatment of metabolic abnormalities linked to menopause and climacteric. View the document
Xinepa patented
XINEPA Easy
Industrial invention patent
n. 0001425919 and n. 102015000010454
The formulation patent n. 0001425919 was granted for showing, in a statistically significant way, the efficiency of the synergy between active substances of XINEPA Easy, for a composition, useful for treatment of neuropathies and/or neuropathic pain. The technology patent n. 102015000010454 was granted for showing, in a statistically significant way, the efficiency of the synergy between active substances of XINEPA Easy, for a composition useful for treatment of neuropathies and/or neuropathic pain. View the document
Milesax patented
MILESAX
Industrial invention patent n. 0001425920
It was granted for showing, in a statistically significant way, the efficiency of the synergy between active substances of MILESAX, for a composition with muscle relaxant and anti-inflammatory activities. View the document
Related news